Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

OMED $18.08 0.9200 +5.36%
GLYC $7.80 0.3000 +4.00%
RNN $0.73 0.0268 +3.79%
XLRN $24.92 0.7100 +2.93%
MEIP $6.91 0.1800 +2.67%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

THLD $3.97 -0.5000 -11.19%
CYTK $3.81 -0.3300 -7.97%
CNDO $1.80 -0.1500 -7.69%
CERU $3.61 -0.3000 -7.67%
ONTX $4.33 -0.3500 -7.48%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

MRI Of The Spine Identifies Smoldering Myeloma Patients At High Risk Of Progressing To Multiple Myeloma

(The Myeloma Beacon) Aug 26, 2014 - A recently published Greek study provides updated data on the sig­nif­i­cance of MRI-detected focal lesions in the spine in patients with smol­der­ing myeloma.
read article 

Surgery for Spinal Metastasis Up From 2000 to 2009 in U.S.

(Doctors Lounge/HealthDay News) Aug 29, 2014 - From 2000 to 2009 there was an increase in surgical treatment for spinal metastasis in the United States, which was accompanied by increased complication rates and costs, according to a study published in the Sept. 1 issue of The Spine Journal.
read article 

Factors ID'd for Late Hospice Admission for Cancer Patients

(Doctors Lounge/HealthDay News) Aug 29, 2014 — For patients with cancer, factors associated with late admission to hospice have been identified, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
read article 

Fears of Addiction Keep Cancer Patients from Getting Pain Relief

(Reuters Health) Aug 29, 2014 - Fears of opioid abuse and addiction might be keeping patients with advanced cancer from getting enough pain medicine, researchers say.
read article 

Exelixis Drug Fails Pivotal Prostate Cancer Study

(TheStreet) Sept 2, 2014 - The Exelixis cancer drug cabozantinib failed to prolong survival in men with advanced prostate cancer, according to results from a phase III study announced Monday night.
read article 

Johnson & Johnson to Seek Buyer For Cordis Medical-Device Unit

(Wall Street Journal) Aug 28, 2014 - Johnson & Johnson plans to seek a buyer for a business that makes medical devices including stents and catheters, said people familiar with the matter, the latest effort by the health care giant to pare its wide-ranging portfolio.
read article (paid subscription required) 

BioCryst Expects to Begin Ebola Study in Weeks

(Reuters) Aug 29, 2014 - BioCryst Pharmaceuticals Inc said it expects to initiate a study within weeks to test its antiviral in primates for use against Ebola infections.
read article 

Ebola Could Strike 20,000, World Health Agency Says

(New York Times) Aug 28, 2014 - The World Health Organization said on Thursday that the Ebola epidemic was still accelerating and could afflict more than 20,000 people — almost seven times the current number of reported cases — before it could be brought under control.
read article 

FDA is Chastised Over its ‘Action Plan’ to Diversify Clinical Trial Participation

(Wall Street Journal/Pharmalot blog) Aug 28, 2014 - In response to a law passed two years ago, the FDA was directed to assess the extent to which women and minorities are represented in clinical trials and also devise a plan to bolster their participation.
read article (paid subscription required) 

Watch ASCO President Peter Yu, MD, FASCO, Discuss CancerLinQ at Stanford Medicine X 2014 on September 5

(ASCO in Action) Aug 28, 2014 - On Friday, September 5, ASCO President Peter Yu, MD, FASCO, will present on CancerLinQ at Stanford Medicine X 2014, an academic conference that explores how emerging technologies will advance the practice of medicine, improve health, and empower patients to be active participants in their own care.
read article 

NCCN to Host 9th Annual Congress: Hematologic Malignancies™ in New York, NY

(NCCN) Aug 28, 2014 - The National Comprehensive Cancer Network® (NCCN®) will host its 9th Annual Congress: Hematologic Malignancies™ in New York, NY, September 19 – 20, 2014.
read press release 

CPRIT Awards Faculty $26 Million in Prevention, Research, and Recruitment Grants to Help Combat Cancer

(UT Southwestern) Aug 28, 2014 - UT Southwestern Medical Center faculty have received 19 grants totaling more than $26 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to expand cancer screenings, investigate the effectiveness and viability for cancer therapies and radiation treatments, conduct research into cancer biology, and recruitment.
read press release 

Medicare Approval of DNA Colorectal Cancer Test Should Lead to Virtual Colonoscopy Coverage

(ACR) Aug 28, 2014 - The evidence standard that the Centers for Medicare & Medicaid Services (CMS) used to approve Medicare coverage of a stool DNA colorectal cancer (CRC) screening test, under a new joint approval process with the Food and Drug Administration, should be applied to CT colonography (virtual colonoscopy) and other CRC screening exams.
read press release 

Takeda, Lilly Lose Bid to Overturn $9 Billion Actos Award

(Bloomberg) Aug 28, 2014 - Takeda Pharmaceutical Co. and Eli Lilly & Co. lost a bid to have a judge throw out a combined $9 billion punitive-damage award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine.
read article 

Circulating Tumor Cell Clusters More Likely to Cause Metastasis Than Single Cells

(Massachusetts General Hospital) Aug 28, 2014 - Circulating tumor cell clusters – clumps of from 2 to 50 tumor cells that break off a primary tumor and are carried through the bloodstream – appear to be much more likely to cause metastasis than are single CTCs, according to a study from investigators at the MGH Cancer Center.
read press release 

Study Shows Potential Method to Better Control Lung Cancer Using Radiotherapy

(University of Manchester [UK]) Aug 29, 2014 - Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients – potentially offering improved local control and survival.
read press release 

Walking a Mile a Day Can Cut Risk of Dying From Cancer by 40% – Study

(The Guardian [UK]) Aug 28, 2014 - People with two of the most common forms of cancer can cut their risk of dying from the disease by as much as 40% simply by walking for a mile a day, Macmillan Cancer Support has claimed.
read article 

Colon Surgery Site Infections Reduced With Bundled Approach

(Medscape Medical News) Aug 28, 2014 - The use of a bundled approach to prevent surgical site infections (SSIs) after colorectal surgery (CRS) was effective and should help to lower healthcare costs, according to a retrospective study published online August 27 in JAMA Surgery.
read article (free registration required) 

With So Many Terrific New Drugs For Chronic Lymphocytic Leukemia, Why Worry?

(Forbes) Aug 28, 2014 - It’s hard to keep track of practice-changing drugs for chronic lymphocytic leukemia (CLL). Since last November, the FDA has approved three new agents and expanded indications for another to treat this indolent cancer of white blood cells.
read article 

AstraZeneca Boosted by Start of New Cancer Drug Trial

(Reuters) Aug 29, 2014 - Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer.
read article 

NIH Issues Finalized Policy on Genomic Data Sharing

(NIH News) Aug 27, 2014 - The National Institutes of Health has issued a final NIH Genomic Data Sharing (GDS) policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while protecting the privacy of research participants.
read press release 

IBM’s Watson Goes From Jeopardy Player to Scientist Used by J&J

(Bloomberg) Aug 28, 2014 - International Business Machines Corp. wants you to know that its Watson technology can do more than win “Jeopardy!”-- it can now help accelerate scientific research and discoveries.
read article 

FDA Says Johnson & Johnson Recalls Some Jaw Implants

(Reuters) Aug 28, 2014 - Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw following more than a dozen cases of injury.
read article 

Amgen Submits U.S. Application to Sell Cholesterol-Fighting Drug

(Reuters) Aug 28, 2014 - Amgen Inc said it submitted an application to the U.S. Food and Drug Administration to market its cholesterol-lowering drug, evolocumab.
read article 

Officials Announce Ebola Vaccine Trial Launch

(USA Today) Aug 28, 2014 - The USA plans to begin testing an experimental Ebola vaccine next month, but even in the best case, it won't become available until next year.
read article